Guidelines for translational research in heart failure

Enrique Lara-Pezzi, Philippe Menasché, Jean Hugues Trouvin, Lina Badimón, John P A Ioannidis, Joseph C. Wu, Joseph A Hill, Walter J. Koch, Albert F. De Felice, Peter de Waele, Valérie Steenwinckel, Roger J. Hajjar, Andreas M. Zeiher

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Heart failure (HF) remains a major cause of death and hospitalization worldwide. Despite medical advances, the prognosis of HF remains poor and new therapeutic approaches are urgently needed. The development of new therapies for HF is hindered by inappropriate or incomplete preclinical studies. In these guidelines, we present a number of recommendations to enhance similarity between HF animal models and the human condition in order to reduce the chances of failure in subsequent clinical trials. We propose different approaches to address safety as well as efficacy of new therapeutic products. We also propose that good practice rules are followed from the outset so that the chances of eventual approval by regulatory agencies increase. We hope that these guidelines will help improve the translation of results from animal models to humans and thereby contribute to more successful clinical trials and development of new therapies for HF.

Original languageEnglish (US)
Pages (from-to)3-22
Number of pages20
JournalJournal of Cardiovascular Translational Research
Volume8
Issue number1
DOIs
StatePublished - Feb 1 2015

Fingerprint

Translational Medical Research
Heart Failure
Guidelines
Animal Models
Clinical Trials
Therapeutics
Cause of Death
Hospitalization
Safety

ASJC Scopus subject areas

  • Molecular Medicine
  • Genetics
  • Pharmaceutical Science
  • Cardiology and Cardiovascular Medicine
  • Genetics(clinical)

Cite this

Lara-Pezzi, E., Menasché, P., Trouvin, J. H., Badimón, L., Ioannidis, J. P. A., Wu, J. C., ... Zeiher, A. M. (2015). Guidelines for translational research in heart failure. Journal of Cardiovascular Translational Research, 8(1), 3-22. https://doi.org/10.1007/s12265-015-9606-8

Guidelines for translational research in heart failure. / Lara-Pezzi, Enrique; Menasché, Philippe; Trouvin, Jean Hugues; Badimón, Lina; Ioannidis, John P A; Wu, Joseph C.; Hill, Joseph A; Koch, Walter J.; De Felice, Albert F.; de Waele, Peter; Steenwinckel, Valérie; Hajjar, Roger J.; Zeiher, Andreas M.

In: Journal of Cardiovascular Translational Research, Vol. 8, No. 1, 01.02.2015, p. 3-22.

Research output: Contribution to journalArticle

Lara-Pezzi, E, Menasché, P, Trouvin, JH, Badimón, L, Ioannidis, JPA, Wu, JC, Hill, JA, Koch, WJ, De Felice, AF, de Waele, P, Steenwinckel, V, Hajjar, RJ & Zeiher, AM 2015, 'Guidelines for translational research in heart failure', Journal of Cardiovascular Translational Research, vol. 8, no. 1, pp. 3-22. https://doi.org/10.1007/s12265-015-9606-8
Lara-Pezzi E, Menasché P, Trouvin JH, Badimón L, Ioannidis JPA, Wu JC et al. Guidelines for translational research in heart failure. Journal of Cardiovascular Translational Research. 2015 Feb 1;8(1):3-22. https://doi.org/10.1007/s12265-015-9606-8
Lara-Pezzi, Enrique ; Menasché, Philippe ; Trouvin, Jean Hugues ; Badimón, Lina ; Ioannidis, John P A ; Wu, Joseph C. ; Hill, Joseph A ; Koch, Walter J. ; De Felice, Albert F. ; de Waele, Peter ; Steenwinckel, Valérie ; Hajjar, Roger J. ; Zeiher, Andreas M. / Guidelines for translational research in heart failure. In: Journal of Cardiovascular Translational Research. 2015 ; Vol. 8, No. 1. pp. 3-22.
@article{6280a8f8a06c425ca2deddcc72ba002d,
title = "Guidelines for translational research in heart failure",
abstract = "Heart failure (HF) remains a major cause of death and hospitalization worldwide. Despite medical advances, the prognosis of HF remains poor and new therapeutic approaches are urgently needed. The development of new therapies for HF is hindered by inappropriate or incomplete preclinical studies. In these guidelines, we present a number of recommendations to enhance similarity between HF animal models and the human condition in order to reduce the chances of failure in subsequent clinical trials. We propose different approaches to address safety as well as efficacy of new therapeutic products. We also propose that good practice rules are followed from the outset so that the chances of eventual approval by regulatory agencies increase. We hope that these guidelines will help improve the translation of results from animal models to humans and thereby contribute to more successful clinical trials and development of new therapies for HF.",
author = "Enrique Lara-Pezzi and Philippe Menasch{\'e} and Trouvin, {Jean Hugues} and Lina Badim{\'o}n and Ioannidis, {John P A} and Wu, {Joseph C.} and Hill, {Joseph A} and Koch, {Walter J.} and {De Felice}, {Albert F.} and {de Waele}, Peter and Val{\'e}rie Steenwinckel and Hajjar, {Roger J.} and Zeiher, {Andreas M.}",
year = "2015",
month = "2",
day = "1",
doi = "10.1007/s12265-015-9606-8",
language = "English (US)",
volume = "8",
pages = "3--22",
journal = "Journal of Cardiovascular Translational Research",
issn = "1937-5387",
publisher = "Springer New York",
number = "1",

}

TY - JOUR

T1 - Guidelines for translational research in heart failure

AU - Lara-Pezzi, Enrique

AU - Menasché, Philippe

AU - Trouvin, Jean Hugues

AU - Badimón, Lina

AU - Ioannidis, John P A

AU - Wu, Joseph C.

AU - Hill, Joseph A

AU - Koch, Walter J.

AU - De Felice, Albert F.

AU - de Waele, Peter

AU - Steenwinckel, Valérie

AU - Hajjar, Roger J.

AU - Zeiher, Andreas M.

PY - 2015/2/1

Y1 - 2015/2/1

N2 - Heart failure (HF) remains a major cause of death and hospitalization worldwide. Despite medical advances, the prognosis of HF remains poor and new therapeutic approaches are urgently needed. The development of new therapies for HF is hindered by inappropriate or incomplete preclinical studies. In these guidelines, we present a number of recommendations to enhance similarity between HF animal models and the human condition in order to reduce the chances of failure in subsequent clinical trials. We propose different approaches to address safety as well as efficacy of new therapeutic products. We also propose that good practice rules are followed from the outset so that the chances of eventual approval by regulatory agencies increase. We hope that these guidelines will help improve the translation of results from animal models to humans and thereby contribute to more successful clinical trials and development of new therapies for HF.

AB - Heart failure (HF) remains a major cause of death and hospitalization worldwide. Despite medical advances, the prognosis of HF remains poor and new therapeutic approaches are urgently needed. The development of new therapies for HF is hindered by inappropriate or incomplete preclinical studies. In these guidelines, we present a number of recommendations to enhance similarity between HF animal models and the human condition in order to reduce the chances of failure in subsequent clinical trials. We propose different approaches to address safety as well as efficacy of new therapeutic products. We also propose that good practice rules are followed from the outset so that the chances of eventual approval by regulatory agencies increase. We hope that these guidelines will help improve the translation of results from animal models to humans and thereby contribute to more successful clinical trials and development of new therapies for HF.

UR - http://www.scopus.com/inward/record.url?scp=84991221837&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991221837&partnerID=8YFLogxK

U2 - 10.1007/s12265-015-9606-8

DO - 10.1007/s12265-015-9606-8

M3 - Article

C2 - 25604959

AN - SCOPUS:84991221837

VL - 8

SP - 3

EP - 22

JO - Journal of Cardiovascular Translational Research

JF - Journal of Cardiovascular Translational Research

SN - 1937-5387

IS - 1

ER -